•
Jan 23, 2021

Patterson Q3 2021 Earnings Report

Patterson Companies' Q3 2021 operating results were reported, with net sales increasing by 6.5% and adjusted EPS increasing by 23.4%.

Key Takeaways

Patterson Companies reported a 6.5% increase in net sales to $1.55 billion and a 23.4% increase in adjusted EPS to $0.58 per diluted share for the third quarter of fiscal year 2021. The company's performance was driven by strong sales execution and improved operating margins in both the Dental and Animal Health segments.

Net sales increased 6.5% year-over-year to $1.55 billion, with internal sales up 6.9%.

Adjusted operating margin increased by 30 bps to 4.6%.

Dental segment internal sales increased 3.6%, driven by 13.6% growth in consumables.

Animal Health segment internal sales increased 10.0%, driven by 20.7% growth in companion animal sales.

Total Revenue
$1.55B
Previous year: $1.46B
+6.5%
EPS
$0.58
Previous year: $0.47
+23.4%
Adjusted Operating Margin
4.6%
Previous year: 4.3%
+7.0%
Gross Profit
$325M
Previous year: $312M
+4.1%
Cash and Equivalents
$156M
Previous year: $106M
+46.9%
Free Cash Flow
-$189M
Previous year: -$164M
+14.8%
Total Assets
$2.85B
Previous year: $3.51B
-18.9%

Patterson

Patterson

Patterson Revenue by Segment

Forward Guidance

Due to the continued uncertainty surrounding the COVID-19 pandemic and its impact on business operations, Patterson is not providing fourth-quarter fiscal 2021 financial guidance at this time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income